2013
DOI: 10.1016/j.genhosppsych.2013.03.009
|View full text |Cite
|
Sign up to set email alerts
|

Furthering the reliable and valid measurement of mental health screening, diagnoses, treatment and outcomes through health information technology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(29 citation statements)
references
References 75 publications
0
28
0
Order By: Relevance
“…One example is increasing Health Information Technology (HIT) applications aimed at advancing mental health screening and mental health interventions within primary care [52][53][54][55][56][57]. The DCAT study recently completed testing of automated patient calls to assist timepressured medical and behavioral providers by routinely screening and monitoring patient depression symptoms, treatment adherence and communication with providers [30,31].…”
Section: Discussionmentioning
confidence: 99%
“…One example is increasing Health Information Technology (HIT) applications aimed at advancing mental health screening and mental health interventions within primary care [52][53][54][55][56][57]. The DCAT study recently completed testing of automated patient calls to assist timepressured medical and behavioral providers by routinely screening and monitoring patient depression symptoms, treatment adherence and communication with providers [30,31].…”
Section: Discussionmentioning
confidence: 99%
“…This flawed approach fails to take into account the complexity of neurobehavioural disorders in 3 ways. 9,[34][35][36][37] First, patient subgroups are defined by baseline prerandomization markers that are hypothesized to modulate the effect size of the intervention (i.e., modulators), an approach commonly used in cardiovascular disease, for example. This approach assumes that the disorder's pathophysiol-ogy is well-known, such that a static baseline marker (such as a genotype or other biomarker) can reliably enrich the sample (i.e., distinguish a patient subgroup that is most likely to benefit from a treatment).…”
Section: Shortcomings Of the Current Precision Medicine Approach In Rmentioning
confidence: 99%
“…, the quantitative analysis is shown, we found that global averages varied for the subscales of anxiety/insomnia and social dysfunction, whose means are high and are between (M= 1.01; DE = 0.885) and (M= 1.21; DE = 0.942) for items(1,5,8,9,10,11,15,16,17,18,20,21).And the other group, formed by the items(2,3,4,6,7,12,13,14,19,22,23) of the subscales of…”
mentioning
confidence: 85%
“…Maintaining adequate overall health in crisis contexts then becomes a growing challenge for health managers on a global scale. In this context, it should be noted that while there are sustained efforts to implement public protection strategies to improve COVID-related infections,19, reports of prevalence of mental illness due to emotional instability have been increasing throughout the period of the first coronavirus outbreak, this exposes the population to the development of psychopathologies and states of deterioration of mental health (3)(4)(5) Previous studies emphasize the importance of identifying in early stages the psychological symptoms of nonpsychiatric population in order to reduce the probability of developing mental disorders and the chronology of clinical symptoms (6,7). However, despite the extensive list of psychological health screening instruments, there are some diagnostic accuracy problems (8).…”
Section: Introductionmentioning
confidence: 99%